Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal carcinoma.

Flavone acetic acid (FAA), 8.6 gm-2 has been administered by 6h intravenous infusion to 19 patients with advanced colorectal carcinoma and 15 patients with advanced malignant melanoma. The drug associated toxicity was generally mild and as predicted from the phase I study. No responses were seen in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerr, D. J., Maughan, T., Newlands, E., Rustin, G., Bleehen, N. M., Lewis, C., Kaye, S. B.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1989
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247346/
https://www.ncbi.nlm.nih.gov/pubmed/2803908
Descripción
Sumario:Flavone acetic acid (FAA), 8.6 gm-2 has been administered by 6h intravenous infusion to 19 patients with advanced colorectal carcinoma and 15 patients with advanced malignant melanoma. The drug associated toxicity was generally mild and as predicted from the phase I study. No responses were seen in either disease.

Ejemplares similares